Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:ACAIOTCMKTS:HDIINASDAQ:NMRDOTCMKTS:RCAR On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeACAISafeplus International$0.00$0.00▼$0.00$3K1.12N/AN/AHDIIHypertension Diagnostics$0.00$0.00▼$0.00$5K1.24193,800 shsN/ANMRDNemaura Medical$0.00$0.00▼$0.06$4K0.517,917 shs4 shsRCARRenovaCare$0.00$0.00▼$0.30$9K-99.34N/AN/AThe Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceACAISafeplus International0.00%0.00%0.00%0.00%-20.00%HDIIHypertension Diagnostics0.00%0.00%0.00%0.00%-50.00%NMRDNemaura Medical0.00%0.00%0.00%-50.00%-99.78%RCARRenovaCare0.00%0.00%0.00%0.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationACAISafeplus InternationalN/AN/AN/AN/AN/AN/AN/AN/AHDIIHypertension DiagnosticsN/AN/AN/AN/AN/AN/AN/AN/ANMRDNemaura Medical0.935 of 5 stars0.03.00.04.50.61.70.0RCARRenovaCareN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceACAISafeplus International 0.00N/AN/AN/AHDIIHypertension Diagnostics 0.00N/AN/AN/ANMRDNemaura Medical 0.00N/AN/AN/ARCARRenovaCare 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookACAISafeplus InternationalN/AN/AN/AN/AN/AN/AHDIIHypertension DiagnosticsN/AN/AN/AN/AN/AN/ANMRDNemaura Medical$3.02K0.00N/AN/A($0.41) per share0.00RCARRenovaCareN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateACAISafeplus InternationalN/AN/A0.00N/AN/AN/AN/AN/AN/AHDIIHypertension DiagnosticsN/AN/A0.00N/AN/AN/AN/AN/AN/ANMRDNemaura Medical-$14.14M-$0.39N/AN/AN/AN/AN/AN/AN/ARCARRenovaCareN/AN/A0.00N/AN/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthACAISafeplus InternationalN/AN/AN/AN/AN/AHDIIHypertension DiagnosticsN/AN/AN/AN/AN/ANMRDNemaura MedicalN/AN/AN/AN/AN/ARCARRenovaCareN/AN/AN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipACAISafeplus InternationalN/AHDIIHypertension DiagnosticsN/ANMRDNemaura Medical4.41%RCARRenovaCareN/AInsider OwnershipCompanyInsider OwnershipACAISafeplus International4.02%HDIIHypertension Diagnostics40.00%NMRDNemaura Medical40.42%RCARRenovaCare0.86%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableACAISafeplus International225.38 million24.36 millionNot OptionableHDIIHypertension Diagnostics2,01752.39 million170.87 millionNot OptionableNMRDNemaura Medical4040.35 million24.04 millionNo DataRCARRenovaCare187.35 millionN/ANot OptionableACAI, RCAR, HDII, and NMRD HeadlinesRecent News About These CompaniesRenovaCare Inc. Provides Notice of Proposed Derivative Settlement to All Record Holders and Beneficial Owners of RenovaCare, Inc.February 12, 2025 | businesswire.comHagens Berman Sobol Shapiro LLP Announces Proposed Class Action Settlement on Behalf of Purchasers of RenovaCare Securities - RCARJanuary 17, 2025 | globenewswire.comRenovaCare $2M Deal in Stock Promotion LawsuitSeptember 25, 2024 | usaherald.comCompare Car Insurance Rates for August 2024August 15, 2024 | nerdwallet.comThe Most Luxurious Cars, SUVs, and Trucks You Can Buy in 2024July 27, 2024 | roadandtrack.comRenovaCare Inc.July 23, 2024 | wsj.comRenovaCare, Inc. (RCAR)May 24, 2024 | finance.yahoo.comRenovaCare Stock (OTC:RCAR), Quotes and News SummaryMay 24, 2024 | benzinga.comEarly Cars: Fact Sheet for ChildrenMay 14, 2024 | si.eduSerra ToyotaApril 22, 2024 | cars.comBest Midsize Car for 2022April 19, 2024 | cnet.comUsed cars for sale under $5,000 near meApril 19, 2024 | cars.comCheapest Car Insurance New JerseyApril 18, 2024 | marketwatch.comThe best booster car seats of 2024April 17, 2024 | autoblog.comUsed cars for sale under £5,000April 10, 2024 | motors.co.ukBest Hybrid Cars for 2024 & 2025April 9, 2024 | autoweek.comEuro Car Parts Discount Codes April 2024April 8, 2024 | independent.co.ukBitcoin Laundering, 'Gucci Goddess' Army Swindle And Healthcare 'Pump And Dump' Scam: Financial Crime WeeklyMarch 1, 2024 | benzinga.comRenovaCare, Inc. (RCAR) Stock Historical Prices & Data - Yahoo FinanceOctober 12, 2023 | finance.yahoo.comGlobal Technology Acquisition Corp I Unit (GTACU)August 9, 2023 | investing.comNew MarketBeat Followers Over TimeACAI, RCAR, HDII, and NMRD Company DescriptionsSafeplus International OTCMKTS:ACAISafeplus International Holdings Limited develops and markets various technologies for the medical device industries. It is seeking partners to monetize its patented technologies, including biothermal power supply and pulsewidth modulation technology to enhance the performance of pacemakers and neurostimulators, and photonics and nanomaterials patents. The company was formerly known as Biophan Technologies, Inc. and changed its name to Safeplus International Holdings Limited in September 2020. Safeplus International Holdings Limited was founded in 1963 and is based in Pittsford, New York.Hypertension Diagnostics OTCMKTS:HDIIHypertension Diagnostics, Inc. designs, develops, manufactures, and markets proprietary noninvasive medical devices that detect subtle changes in the elasticity of arteries in the United States and internationally. It offers CVProfilor, which allows a physician to non-invasively assess the elasticity of small and large arteries, of which small artery elasticity is the earliest and sensitive marker of cardiovascular disease. The company offers CVProfilor DO-2020, which provides a patient's arterial elasticity indices used in the assessment for underlying vascular disease; CVProfilor MD-3000 that offers a sensitive and specific guide to the presence of blood vessel disease; and HD/PulseWave CR-2000 research cardiovascular profiling system, which provides researchers and scientists with a non-invasive means to assess arterial elasticity in support of human research in various areas. Its products collect 30 seconds of blood pressure waveform data, perform an analysis of the digitized blood pressure waveforms, and generate a CVProfile report that contains information on blood pressure, heart rate, pulse pressure, body surface area, body mass index, and C1-large and C2-small artery elasticity indices. The company sells its products to primary care physicians, cardiologists, health care professionals, trained medical personnel, research investigators at academic medical research centers, government institutes, cardiovascular specialists, and pharmaceutical firms. It markets its products through a representative organization in the United States. Hypertension Diagnostics, Inc. was founded in 1988 and is based in Richmond Hill, Canada.Nemaura Medical NASDAQ:NMRDNemaura Medical Inc., a medical technology company, manufactures continuous glucose monitoring system in the United States. It offers sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York.RenovaCare OTCMKTS:RCARRenovaCare, Inc., a development-stage biotech and medical device company, focuses on the research, development, and commercialization of autologous cellular therapies for use in medical and aesthetic applications. It is developing CellMist System, a treatment methodology for cell isolation for the regeneration of human skin cells; and SkinGun, a solution sprayer device for delivering the cells to the treatment area. RenovaCare, Inc. has a strategic collaboration StemCell Systems GmbH for isolating and spraying self-donated stem cells to regenerate tissues and organs. The company was formerly known as Janus Resources, Inc. and changed its name RenovaCare, Inc.,to RenovaCare, Inc. in January 2014. RenovaCare, Inc. was incorporated in 1983 and is based in Scottsdale, Arizona. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 06/09 - 06/13 Alphabet Enters a Bull Market: Is It Time to Buy? Ouster Soars 27% as DoD Grants First 3D LiDAR Approval for Drones RH Stock Rockets on Surprise Profit and Tariff Shift Super Micro Computer Stock: 2 Levels Smart Money Is Watching Intel's Price Spikes: Noise, or the First Notes of a Turnaround? IBM Up 10 Days in a Row: What’s Driving the Winning Streak? SoFi Stock’s Next Test: Can It Justify Its Premium Valuation? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
